High expression of B7-H3 on tumor tissue is associated with poor clinical outcome and lymph node metastasis (43), and several studies report first evidence that B7-H3 positive tumor cell fractions may be enriched for cancer stem cells (44–46). This evidence concerns the gene CD276 and cancer.